Prostate Cancer Center
The UCSF Prostate Cancer Center provides comprehensive, cutting-edge care to patients with prostate cancer as well as men at high risk of developing the condition. 重点是早期筛查和发现, 我们中心提供一系列的服务, from active surveillance for low-risk cancers to the latest techniques for cancers at all stages, whether localized (局限于前列腺)或 advanced (扩散到骨盆以外的组织). UCSF is a major research center for later-stage prostate cancer and offers the best treatments available.
We also connect patients with integrative medicine services (in which experts combine complementary therapies with mainstream treatments), 营养和生活方式咨询, 支持小组和教育资源. 我们的使命是优化患者在治疗期间及以后的生活质量.
我们的专家团队包括泌尿系统癌症外科十大赌博平台排行榜, radiation oncologists, 医学肿瘤学家和其他专科十大赌博平台排行榜. 除了照顾病人, our doctors are at the forefront of prostate cancer research and strive to quickly translate new findings into more effective methods of prevention, diagnosis and treatment.
前列腺癌患者会议
Co-hosted by the UCSF Helen Diller Family Comprehensive Cancer Center and the California Prostate Cancer Coalition, this annual conference provides an outstanding opportunity to hear the latest on prostate cancer care from leading experts. Explore videos from recent conferences that can help you make informed decisions around monitoring, treatment and more.
处理治疗副作用
Patient education
Care providers
-
Peter Carroll
MD, MPH
Urologic oncologist -
Matthew Cooperberg
MD, MPH
Urologic oncologist -
Laura Crocitto
MD
Urologic oncologist -
Maxwell V. Meng
MD
Urologic oncologist -
Hao Nguyen
MD, PhD
Urologic oncologist -
Anobel Odisho
MD, MPH
Urologic oncologist -
Sima Porten
MD, MPH
Urologic oncologist -
Katsuto Shinohara
MD
Urologic oncologist -
Samuel L. Washington III
MD, MAS
Urologic oncologist -
Stephanie Haiba Collier
PA-C, MS
Physician assistant -
Krisztina Emodi
FNP, MPH, CNS
Nurse practitioner -
Jocelyn Malott
FNP, MSN
Family nurse practitioner -
Sian Mara
PA
Physician assistant -
Sara McRorey
PA
Physician assistant -
Tia Briana Watson
NP, MSN
Nurse practitioner
-
Rahul Aggarwal
MD
Genitourinary oncologist -
Hala Borno
MD
Medical oncologist -
Rohit Bose
MD, PhD
Genitourinary oncologist -
Jonathan Chou
MD, PhD
Genitourinary oncologist -
Arpita Desai
MD
Genitourinary oncologist -
Kelly Fitzgerald
MD
Genitourinary oncologist -
Lawrence H. Fong
MD
Genitourinary oncologist -
Terence W. Friedlander
MD
Genitourinary oncologist -
Vadim S. Koshkin
MD
Genitourinary oncologist -
Akshiv Malhotra
MD
Medical oncologist -
Eric J. Small
MD, FASCO
Genitourinary oncologist
Our locations (1)
Our research initiatives
-
UCSF前列腺癌项目研究
The UCSF Prostate Cancer Program conducts research aimed at discovering how prostate cancer develops and progresses, finding the best methods of predicting patient outcomes and developing treatments to improve these outcomes
-
加州大学旧金山分校海伦·迪勒家庭综合癌症中心
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. 这包括对免疫疗法等主题的研究, BRCA突变和分子诊断检测.
Clinical trials
A Phase 1 Safety and Efficacy Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy Using the da Vinci® Surgical System With Firefly® Fluorescent Imaging
This is a Phase 1, single-site, interventional clinical trial evaluating the safety and efficacy of IS-002 intravenous (IV) injection for fluorescent identification and delineation of the positive cancer margins and metastatic lymph nodes during prostatectomy surgery using the da Vinci® X/Xi Surgical System with Firefly® Fluorescent Imaging.
Learn more一项随机临床试验:运动vs. 选择主动监测前列腺癌的男性的常规护理
The AS RCT study is a randomized controlled trial of 16-weeks aerobic exercise (home-based walking) vs. 主动监测前列腺癌患者的常规护理.
Learn more饮食的随机对照试验 & 前列腺癌患者的运动干预(前列腺8-II)
The Prostate 8-II study is a 2-year randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prostate cancer.
Learn moreA Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.
Contact Patricia Li177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
This phase Ib trial studies the dose and schedule of 177Lu-PSMA-617 and pembrolizumab in treating patients with castration-resistant prostate cancer that has spread to other places in the body.
Contact Patricia LiA Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
This study will test the safety and efficacy of FOR46 given every 21 days to patients with metastatic castration-resistant prostate cancer.
Contact Nela PawlowskaNRG- GU 008: Randomized Phase III Trial Incorporating Abiraterone Acetate with Prednisone and Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy
这个III期试验研究了添加阿帕鲁胺的效果, abiraterone acetate, and prednisone to the usual hormone therapy and radiation therapy works compared to the usual hormone therapy and radiation therapy in treating patients with node-positive prostate cancer after surgery.
Learn morePlan your visit
What to Bring
- Photo I.D.
- Health insurance card
- 保险授权,如果需要的话
- 十大赌博平台排行榜推荐,如果需要的话
- 最近的检查结果与你的病情有关
- 你的药物清单,包括剂量,还有你过敏的药物
- 你可能有问题的清单
- 记笔记的工具或纸